Kintara Therapeutics Inc (NASDAQ:KTRA)
| 3.34 Delayed Data As of Jun 08 |  0.00 / 0.00%Today’s Change | 2.70 Today|||52-Week Range 20.00 | -51.52% Year-to-Date |
Latest KTRA News | Press Releases
No recent news for Kintara Therapeutics Inc.
Today’s Trading
| Previous close | 3.34 |
| Today’s open | 3.34 |
| Day’s range | 3.34 - 3.34 |
| Volume | 1 |
| Average volume (3 months) | 34,742 |
| Market cap | $6.2M |
Data as of 3:31pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +67.82% |
| Earnings growth (this year) | +83.50% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| ---- | ||
| ADMPAdamis Pharmaceutica... | -0.02 | -0.98% |
| RDHLRedhill Biopharma Lt... | -0.12 | -6.22% |
| NBSENeuBase Therapeutics... | -0.00 | -0.86% |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | September 25, 2023 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
